Posterolateral Arthrodesis in Lumbar Spine Surgery Using Autologous Platelet-Rich Plasma and Cancellous Bone Substitute: An Osteoinductive and Osteoconductive Effect
26 January 2014
07 April 2014
03 May 2014 (eFirst)
Study Design Prospective cohort study.
Objectives To analyze the effectiveness and practicality of using cancellous bone substitute with platelet-rich plasma (PRP) in posterolateral arthrodesis.
Methods Twenty consecutive patients underwent posterolateral arthrodesis with implantation of cancellous bone substitute soaked with PRP obtained directly in the operating theater on the right hemifield and cancellous bone substitute soaked with saline solution on the right.
Results Computed tomography scans at 6 and 12 months after surgery were performed in all patients. Bone density was investigated by comparative analysis of region of interest. The data were analyzed with repeated-measures variance analyses with value of density after 6 months and value of density after 12 months, using age, levels of arthrodesis, and platelet count as covariates. The data demonstrated increased bone density using PRP and heterologous cancellous block resulting in an enhanced fusion rate during the first 6 months after surgery.
Conclusions PRP used with cancellous bone substitute increases the rate of fusion and bone density joining osteoinductive and osteoconductive effect.
- 1 Gibson JN, Grant IC, Waddell G. The Cochrane review of surgery for lumbar disc prolapse and degenerative lumbar spondylosis. Spine (Phila Pa 1976) 1999; 24 (17) 1820-1832
- 2 Glassman SD, Carreon LY, Djurasovic M , et al. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976) 2008; 33 (26) 2843-2849
- 3 Park JJ, Hershman SH, Kim YH. Updates in the use of bone grafts in the lumbar spine. Bull Hosp Jt Dis (2013) 2013; 71 (1) 39-48
- 4 Acebal-Cortina G, Suárez-Suárez MA, García-Menéndez C, Moro-Barrero L, Iglesias-Colao R, Torres-Pérez A. Evaluation of autologous platelet concentrate for intertransverse lumbar fusion. Eur Spine J 2011; 20 (Suppl. 03) 361-366
- 5 Lee JH, Chang BS, Jeung UO, Park KW, Kim MS, Lee CK. The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion. Clin Orthop Surg 2011; 3 (3) 238-244
- 6 Tsai CH, Hsu HC, Chen YJ, Lin MJ, Chen HT. Using the growth factors-enriched platelet glue in spinal fusion and its efficiency. J Spinal Disord Tech 2009; 22 (4) 246-250
- 7 Landi A, Tarantino R, Marotta N , et al. The use of platelet gel in postero-lateral fusion: preliminary results in a series of 14 cases. Eur Spine J 2011; 20 (Suppl. 01) S61-S67
- 8 Motomiya M, Ito M, Takahata M , et al. Effect of hydroxyapatite porous characteristics on healing outcomes in rabbit posterolateral spinal fusion model. Eur Spine J 2007; 16 (12) 2215-2224
- 9 Bose B, Balzarini MA. Bone graft gel: autologous growth factors used with autograft bone for lumbar spine fusions. Adv Ther 2002; 19 (4) 170-175
- 10 Jenis LG, Banco RJ, Kwon B. A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J 2006; 6 (1) 14-20
- 11 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27 (3) 158-167
- 12 Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9 (6) 669-676
- 13 Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011; 39 (10) 2135-2140
- 14 Vaccaro AR, Sharan AD, Tuan RS , et al. The use of biologic materials in spinal fusion. Orthopedics 2001; 24 (2) 191-197, quiz 198–199
- 15 Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009; 97 (2) 110-118
- 16 Brew EC, Mitchell MB, Harken AH. Fibroblast growth factors in operative wound healing. J Am Coll Surg 1995; 180 (4) 499-504